3-(3-Chlorophenyl)oxetan-3-amine hydrochloride

Catalog No. :
ACDGCJ083
CAS No. :
1332765-66-8
Molecular Formula :
C9H11Cl2NO
Molecular Weight :
220.10

IUPAC Name:3-(3-chlorophenyl)oxetan-3-amine hydrochloride

3-(3-Chlorophenyl)oxetan-3-amine hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$301.00Login to see priceIn stockInquiry
250mg95%$481.00Login to see priceIn stockInquiry
500mg95%$800.00Login to see priceIn stockInquiry
1g95%$1200.00Login to see priceIn stockInquiry
5g95%$3600.00Login to see priceInquiryInquiry
10g95%$5999.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(3-Chlorophenyl)oxetan-3-amine hydrochloride
IUPAC Name3-(3-chlorophenyl)oxetan-3-amine hydrochloride
MDL No.MFCD19381730
Molecular FormulaC9H11Cl2NO
Molecular Weight220.10
SMILESNC1(C2=CC=CC(Cl)=C2)COC1.[H]Cl
InChI KeyHEFFEMSQOGSELE-UHFFFAOYSA-N
Synonym3-(3-Chlorophenyl)oxetan-3-amine hydrochloride | 1332765-66-8 | 1332920-60-1 | 3-(3-CHLOROPHENYL)-3-OXETANAMINE HYDROCHLORIDE | 3-(3-CHLOROPHENYL)OXETAN-3-AMINE HCL | 3-(3-chlorophenyl)oxetan-3-amine;hydrochloride | MFCD19381730 | 3-Oxetanamine, 3-(3-chlorophenyl)-, hy
CAS No.1332765-66-8
PubChem CID53256990

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACDGCJ083 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDGCJ083 route product structure diagram
    ACDGCJ0831332765-66-8 In Stock
Inquiry

2. ACDGCJ083 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDGCJ083 route product structure diagram
    ACDGCJ0831332765-66-8 In Stock
Inquiry

Comments (0)